FindTrial
Sign In

To analyse whether Dexmedetomidine(Central Alpha 2 Agonist) can be used safely as a sedative/analgesic agent In patients undergoing Laparoscopic Tubal Ligation And with/without MTP

Safety and efficacy of Dexmedetomidine for procedural sedation during combined laparoscopic interval tubal ligation and medical termination of pregnancy- a randomized, controlled, double-blinded trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010353
Enrollment
80
Registered
2017-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- FEMALE PATIENTS SCHEDULED FOR LAPAROSCOPIC TUBAL LIGATION WITH MEDICAL TERMINATION OF PREGNANCY

Interventions

Intervention1: DEXMEDETOMIDINE: CENTRAL ALPHA 2 AGONIST, 1 MIC/KG OVER 10 MINUTES FOLLOWED BY 0.7 MIC/KG/HOUR Control Intervention1: MIDAZOLAM AND FENTANYL: MIDAZOLAM 2MG IV BOLUS (SHPRT ACTING BENZOD

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients(ASA I and II) scheduled for laparoscopic interval tubal ligation with MTP under local anesthesia(procedure time 15 TO 30 minutes)

Exclusion criteria

Exclusion criteria: 1. Not willing to participate 2. patient having local anesthetic hypersensitivity 3. patients With uncontrolled co morbid condition 4. Inadequate fasting BMI>=35 concurrent surgeries difficult airway

Design outcomes

Primary

MeasureTime frame
1. tolerance and comfort of the patients during uterine evacuation and laparoscopic tubal ligation performed under local anesthesia. 2. pain scores after laparoscopic tubal ligation with uterine evacuation. Timepoint: 1. during the procedure and post operatively every 15 minutes and sos till the patient is discharged—

Secondary

MeasureTime frame
adverse effects like hypotension, bradycardia during the procedure and post op PONV, sedation 2.discharge readinessof the patient 3. patient satisfaction score and surgeons copmfort scoreTimepoint: 1.intraoperatively 2. post operatively every 15 minutes and sos till the patient is discharged—

Countries

India

Contacts

Public ContactDr Rajeshwari Subramaniam

AIIMS

drsrajeshwari@gmail.com9894776154

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026